Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 3
Submit an article Journal homepage
141
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art

Onur Sinan Devecia Department of Cardiology, Cukurova University Faculty of Medicine, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0002-8427-4097
ORCID Icon,
Sercan Okutucub Department of Cardiology, Memorial Ankara Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-2001-929X
ORCID Icon,
Sefik Gorkem Fatihogluc Department of Cardiology, Iskenderun State Hospital, Hatay, TurkeyCorrespondence[email protected]
&
Ali Otob Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey
Pages 196-203 | Received 31 Jan 2021, Accepted 22 Mar 2021, Published online: 08 Apr 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vlatka Reskovic Luksic, Jadranka Separovic Hanzevacki, Mai-Linh Nguyen Trung, Hélène Petitjean & Patrizio Lancellotti. (2024) The burden and challenges of managing aortic stenosis. Acta Cardiologica 79:1, pages 98-100.
Read now

Articles from other publishers (1)

Beatriz Eguzkitza, David Oks, José A. Navia, Guillaume Houzeaux, Constantine Butakoff, María Fisa, Ariadna Campoy Millán & Mariano Vázquez. (2023) Performance assessment of an electrostatic filter-diverter stent cerebrovascular protection device. Is it possible not to use anticoagulants in atrial fibrilation elderly patients?. Frontiers in Cardiovascular Medicine 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.